Regimens that have not proven to be superior to a standard-of-care comparison and are thus unlikely to be expanded upon unless new evidence comes forward. This page is primarily to drive the HemOnc Ontology and for historic interest.
Contents
1 Regimens composed solely of approved drugs
1.1 3M 1.2 5-FU & RT 1.3 7+3i & Clofarabine 1.4 7+3i & Lenalidomide 1.5 7+4i 1.6 7+5d 1.7 Abiraterone & Enzalutamide 1.8 ABVP 1.9 ACP 1.10 Afatinib & Vinorelbine 1.11 A-ICE 1.12 AME 1.13 Amsacrine & IDAC 1.14 ATRA, Cytarabine, Etoposide 1.15 AVML 1.16 Binimetinib monotherapy 1.17 Bortezomib & Bevacizumab 1.18 Bortezomib & Siltuximab 1.19 BTH (Docetaxel) 1.20 BTOC 1.21 CAD 1.22 Capecitabine & Cisplatin (CX) & Bevacizumab 1.23 Capecitabine & Cisplatin (CX) & Ramucirumab 1.24 Capecitabine & Ruxolitinib 1.25 Capecitabine & Sorafenib 1.26 Capecitabine & Sunitinib 1.27 Capecitabine & Vinflunine 1.28 Capecitabine & Vinorelbine (NX) 1.29 Capecitabine, Cisplatin, Cetuximab, RT 1.30 Capecitabine, Erlotinib, RT 1.31 CarboMIP 1.32 Carboplatin & Epirubicin 1.33 Carboplatin & Paclitaxel (CP) & Bexarotene 1.34 Carboplatin & Paclitaxel (CP) & Cetuximab 1.35 Carboplatin & Paclitaxel (CP) & Erlotinib 1.36 Carboplatin & Paclitaxel (CP) & PLD 1.37 Carboplatin & Paclitaxel (CP) & Sorafenib 1.38 Carboplatin & Paclitaxel (CP) & Topotecan 1.39 Carboplatin & Topotecan 1.40 CBM 1.41 CCG 1.42 Carboplatin & Etoposide (CE) & Ipilimumab 1.43 Carboplatin & Etoposide (CE) & Thalidomide 1.44 CIB 1.45 Cisplatin & Methotrexate 1.46 Cisplatin & Treosulfan 1.47 Cisplatin & Vincristine 1.48 Cisplatin, Avelumab, RT 1.49 Cisplatin, Pemetrexed, RT 1.50 CODE 1.51 CYVADIC 1.52 DBCT 1.53 Docetaxel & Gefitinib 1.54 Docetaxel & Lapatinib 1.55 Docetaxel & Pertuzumab 1.56 Docetaxel & Selumetinib 1.57 Docetaxel & Sunitinib 1.58 Docetaxel & ziv-Aflibercept 1.59 Doxorubicin & Etoposide 1.60 Doxorubicin & Paclitaxel 1.61 Doxorubicin & Sorafenib 1.62 Doxorubicin & Streptozocin 1.63 Doxorubicin & Vinorelbine 1.64 EAP 1.65 ECVBP 1.66 ELF 1.67 Encorafenib monotherapy 1.68 EP & Ipilimumab 1.69 EP, Tamoxifen, RT 1.70 Erlotinib & Sunitinib 1.71 Everolimus & Vinorelbine 1.72 E-GEMOX 1.73 FAP 1.74 FEC & HP 1.75 FLA 1.76 FLAG-Ida & GO 1.77 FLAI 1.78 FOLF-CB 1.79 FOLFIRI & Regorafenib 1.80 FOLFIRI & Simvastatin 1.81 FOLFIRI & Sunitinib 1.82 FULV & Trimetrexate 1.83 GVP 1.84 ICE, ATRA, GO 1.85 Ixabepilone & Bevacizumab 1.86 ME 1.87 MEV 1.88 MFL 1.89 MFT 1.90 Mitoxantrone & Hydrocortisone 1.91 MMF 1.92 MPP 1.93 MTP 1.94 MVC 1.95 NIP 1.96 PD & Pembrolizumab 1.97 PEI 1.98 PELF 1.99 PGT 1.100 PGV 1.101 Pemetrexed & Cetuximab 1.102 Pemetrexed & Vandetanib 1.103 Pixantrone & Rituximab 1.104 PVI 1.105 R-BEACOPP 1.106 R-MegaCHOEP 1.107 Realgar-Indigo naturalis formula monotherapy 1.108 TCG 1.109 TCHL (Docetaxel) 1.110 TCL (Docetaxel) 1.111 TEC 1.112 TG+Bev 1.113 Paclitaxel & Trastuzumab (TH) & Everolimus 1.114 TL (Docetaxel) 1.115 TPCV 1.116 TX+Bev 1.117 VADx 1.118 VAPEC-B 1.119 VBM (Vinblastine) 1.120 VCE 1.121 Vinorelbine & Hydrocortisone 1.122 VNC 1.123 VPV 1.124 VTDC
2 Regimens that contain experimental (unapproved) drugs
Regimens composed solely of approved drugs 3M 3M: M M M
Regimen Chemotherapy 5-FU & RT Regimen Chemotherapy Radiotherapy 7+3i & Clofarabine 7+3i & Clofarabine: 7 3 i
Regimen Chemotherapy 7+3i & Lenalidomide 7+3i & Lenalidomide: 7 3 i
Regimen Chemotherapy Targeted therapy 7+4i 7+4i: 7 4 i
Regimen Chemotherapy 7+5d 7+5d: 7 5 d
Regimen Chemotherapy Abiraterone & Enzalutamide Regimen Endocrine therapy ABVP Regimen Chemotherapy ACP ACP: A C P
Regimen Immunotherapy Chemotherapy Afatinib & Vinorelbine Regimen Chemotherapy Targeted therapy A-ICE A-ICE: A I C E
Regimen Targeted therapy Chemotherapy AME AME: A M E
Regimen Chemotherapy Amsacrine & IDAC Amsacrine & IDAC: Amsacrine & I D A C
Regimen Chemotherapy ATRA, Cytarabine, Etoposide Regimen Targeted therapy Chemotherapy AVML Regimen Chemotherapy Supportive therapy Binimetinib monotherapy Regimen Targeted therapy Bortezomib & Bevacizumab Regimen Targeted therapy Bortezomib & Siltuximab Regimen Targeted therapy BTH (Docetaxel) BTH: B T H
Regimen Chemotherapy Targeted therapy BTOC BTOC: B T O C
Regimen Chemotherapy CAD CAD: C A D
Regimen Chemotherapy Capecitabine & Cisplatin (CX) & Bevacizumab Regimen Chemotherapy Targeted therapy Capecitabine & Cisplatin (CX) & Ramucirumab Regimen Chemotherapy Targeted therapy Capecitabine & Ruxolitinib Regimen Chemotherapy Targeted therapy Capecitabine & Sorafenib Regimen Chemotherapy Targeted therapy Capecitabine & Sunitinib Regimen Chemotherapy Targeted therapy Capecitabine & Vinflunine Regimen Chemotherapy Capecitabine & Vinorelbine (NX) NX: N X
Regimen Chemotherapy Capecitabine, Cisplatin, Cetuximab, RT Regimen Chemotherapy Targeted therapy Radiotherapy Capecitabine, Erlotinib, RT Regimen Chemotherapy Targeted therapy Radiotherapy CarboMIP CarboMIP: Carbo M I P
Regimen Chemotherapy Carboplatin & Epirubicin Regimen Chemotherapy Carboplatin & Paclitaxel (CP) & Bexarotene CP & Bexarotene: C P
Regimen Chemotherapy Carboplatin & Paclitaxel (CP) & Cetuximab CP & Cetuximab: C P
Regimen Chemotherapy Targeted therapy Carboplatin & Paclitaxel (CP) & Erlotinib CP & Erlotinib: C P
Regimen Chemotherapy Targeted therapy Carboplatin & Paclitaxel (CP) & PLD TC & PLD: T C P L D
Regimen Chemotherapy Carboplatin & Paclitaxel (CP) & Sorafenib CP & Sorafenib: C P
Regimen Chemotherapy Targeted therapy Carboplatin & Paclitaxel (CP) & Topotecan TC & Topotecan: T C
Regimen Chemotherapy Carboplatin & Topotecan Regimen Chemotherapy CBM CBM: C B M
Regimen Chemotherapy Targeted therapy CCG CCG: C C G
Regimen Chemotherapy Carboplatin & Etoposide (CE) & Ipilimumab CE & Ipilimumab: C E
Regimen Chemotherapy Immunotherapy Carboplatin & Etoposide (CE) & Thalidomide CE & Thalidomide: C E
Regimen Chemotherapy Targeted therapy CIB CIB: C I B
Regimen Chemotherapy Cisplatin & Methotrexate Regimen Chemotherapy Cisplatin & Treosulfan Regimen Chemotherapy Cisplatin & Vincristine Regimen Chemotherapy Cisplatin, Avelumab, RT Regimen Chemotherapy Immunotherapy Radiotherapy Cisplatin, Pemetrexed, RT Regimen Chemotherapy Radiotherapy CODE CODE: C O D E
Regimen Chemotherapy CYVADIC CYVADIC: CY V AD I C
Regimen Chemotherapy DBCT DBCT: D B C T
Regimen Chemotherapy Endocrine therapy Docetaxel & Gefitinib Regimen Chemotherapy Targeted therapy Docetaxel & Lapatinib Regimen Chemotherapy Targeted therapy Docetaxel & Pertuzumab Regimen Chemotherapy Targeted therapy Docetaxel & Selumetinib Regimen Chemotherapy Targeted therapy Docetaxel & Sunitinib Regimen Chemotherapy Targeted therapy Docetaxel & ziv-Aflibercept Regimen Chemotherapy Targeted therapy Doxorubicin & Etoposide Regimen Chemotherapy Doxorubicin & Paclitaxel Regimen Chemotherapy Doxorubicin & Sorafenib Regimen Chemotherapy Targeted therapy Doxorubicin & Streptozocin Regimen Chemotherapy Doxorubicin & Vinorelbine Regimen Chemotherapy EAP EAP: E A P
Regimen Chemotherapy ECVBP ECVBP: E C V B P
Regimen Chemotherapy ELF ELF: E L F
Regimen Chemotherapy Encorafenib monotherapy Regimen Targeted therapy EP & Ipilimumab EP & Ipilimumab: E P
Regimen Chemotherapy Immunotherapy EP, Tamoxifen, RT EP, Tamoxifen, RT: E P R T
Regimen Chemotherapy Endocrine therapy Radiotherapy Erlotinib & Sunitinib Regimen Targeted therapy Everolimus & Vinorelbine Regimen Chemotherapy Targeted therapy E-GEMOX E-GEMOX: E GEM OX
Regimen Targeted therapy Chemotherapy FAP FAP: F A P
Regimen Chemotherapy Immunotherapy FEC & HP FEC & HP: F E C H P
Regimen Chemotherapy Targeted therapy FLA FLA: FL A
Regimen Chemotherapy FLAG-Ida & GO FLAG-Ida & GO: FL A G Ida G O
Regimen Chemotherapy Growth factor therapy Targeted therapy FLAI FLAI: FL A I F I A
Regimen Chemotherapy FOLF-CB FOLF-CB: FOL F C B
Regimen Chemotherapy Targeted therapy FOLFIRI & Regorafenib FOLFIRI & Regorafenib: FOL F IRI
Regimen Chemotherapy Targeted therapy FOLFIRI & Simvastatin FOLFIRI & Simvastatin: FOL F IRI
Regimen Chemotherapy Targeted therapy FOLFIRI & Sunitinib FOLFIRI & Sunitinib: FOL F IRI
Regimen Chemotherapy Targeted therapy FULV & Trimetrexate FULV & Trimetrexate: 5-FU L V
Regimen Chemotherapy GVP GVP: G V P
Regimen Chemotherapy ICE, ATRA, GO ICE, ATRA: I C E A T R A G O
Regimen Chemotherapy Targeted therapy Ixabepilone & Bevacizumab Regimen Chemotherapy Targeted therapy ME ME: M E
Regimen Chemotherapy MEV MEV: M E V
Regimen Chemotherapy MFL MFL: M F L
Regimen Chemotherapy MFT MFL: M F T
Regimen Chemotherapy Endocrine therapy Mitoxantrone & Hydrocortisone Regimen Chemotherapy Endocrine therapy MMF MMF: M M F
Regimen Chemotherapy MPP MPP: M P P
Regimen Chemotherapy MTP MTP: M T P
Regimen Chemotherapy Targeted therapy MVC MVC: M V C
Regimen Chemotherapy NIP NIP: N I P
Regimen Chemotherapy PD & Pembrolizumab PD & Pembrolizumab: P D
Regimen Targeted therapy Chemotherapy Immunotherapy PEI PEI: P E I
Regimen Chemotherapy PELF PELF: P E L F
Regimen Chemotherapy PGT PGT: P G T
Regimen Chemotherapy PGV PGV: P G V C G V
Regimen Chemotherapy Pemetrexed & Cetuximab Regimen Chemotherapy Targeted therapy Pemetrexed & Vandetanib Regimen Chemotherapy Targeted therapy Pixantrone & Rituximab Regimen Chemotherapy Targeted therapy PVI PVI: P V I V I P
Regimen Chemotherapy R-BEACOPP R-BEACOPP: R B E A C O P P
Regimen Targeted therapy Chemotherapy R-MegaCHOEP R-MegaCHOEP: R Mega C H O E P
Targeted therapy Chemotherapy Realgar-Indigo naturalis formula monotherapy Regimen Targeted therapy TCG TCG: T C G
Regimen Chemotherapy TCHL (Docetaxel) TCHL: T C H L
Regimen Chemotherapy Targeted therapy TCL (Docetaxel) TCL: T C L
Regimen Chemotherapy Targeted therapy TEC TEC: T E C
Regimen Chemotherapy TG+Bev TG+Bev: T G Bev
Regimen Chemotherapy Targeted therapy Paclitaxel & Trastuzumab (TH) & Everolimus TH & Everolimus: T H
Regimen Chemotherapy Targeted therapy TL (Docetaxel) TL: T L
Regimen Chemotherapy Targeted therapy TPCV TPCV: T P C V
Regimen Chemotherapy TX+Bev TX+Bev: T X Bev
Regimen Chemotherapy Targeted therapy VADx VADx: V A D x
Regimen Chemotherapy VAPEC-B VAPEC-B: V A P E C B
Regimen Chemotherapy VBM (Vinblastine) VBM: V B M
Regimen Chemotherapy VCE VCE: V C E
Regimen Chemotherapy Vinorelbine & Hydrocortisone Regimen Chemotherapy Endocrine therapy VNC VNC: V N C
Regimen Chemotherapy VPV VPV: V P V
Regimen Chemotherapy VTDC VTDC: V T D C
Regimen Targeted therapy Chemotherapy Regimens that contain experimental (unapproved) drugs Adavosertib & Gemcitabine Regimen Targeted therapy Chemotherapy Alisertib monotherapy Regimen Targeted therapy Amonafide & Cytarabine Regimen Chemotherapy Buparlisib & Fulvestrant Regimen Targeted therapy Endocrine therapy Buparlisib & Paclitaxel Regimen Targeted therapy Chemotherapy Carboplatin & Paclitaxel (CP) & Cediranib CP & Cediranib: C P
Regimen Chemotherapy Targeted therapy Carboplatin & Paclitaxel (CP) & Trebananib TC & Trebananib: T C
Regimen Chemotherapy Targeted therapy Carboplatin & Paclitaxel (CP) & Veliparib CP & Veliparib: C P
Regimen Chemotherapy Targeted therapy Cediranib monotherapy Regimen Targeted therapy Docetaxel & Bavituximab Regimen Chemotherapy Immunotherapy Docetaxel & Ganetespib Regimen Chemotherapy Targeted therapy Erlotinib & Figitumumab Regimen Targeted therapy Erlotinib & Onartuzumab Regimen Targeted therapy Erlotinib & Tivantinib Regimen Targeted therapy Cisplatin & Gemcitabine (GC) & Veliparib GC & Veliparib: G C
Regimen Chemotherapy Targeted therapy Ibrutinib & Ublituximab Regimen Targeted therapy PLD & Trebananib Regimen Chemotherapy Targeted therapy